Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Adapt Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ADAPT, and what generic and branded alternatives to ADAPT drugs are available?

ADAPT has six approved drugs.

Summary for Adapt

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	6
Patent Litigation for Adapt:	See patent lawsuits for Adapt

Drugs and US Patents for Adapt

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Adaptis	MONTELUKAST SODIUM	montelukast sodium	TABLET;ORAL	209012-001	Apr 24, 2017	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Adaptis	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211020-002	Jan 28, 2019	AB3	RX	No	No		⤷ Try it Free				⤷ Try it Free
Adapt	NARCAN	naloxone hydrochloride	INJECTABLE;INJECTION	016636-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Try it Free				⤷ Try it Free
Adaptis	MONTELUKAST SODIUM	montelukast sodium	TABLET, CHEWABLE;ORAL	209011-002	Apr 18, 2017	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Adaptis	FENOFIBRIC ACID	choline fenofibrate	CAPSULE, DELAYED RELEASE;ORAL	211626-001	Jul 18, 2019	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ADAPT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Nasal Spray	4 mg/spray	➤ Subscribe	2016-07-15

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Harvard Business School

AstraZeneca

Boehringer Ingelheim

Colorcon

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.